DOSE DE-ESCALATION TO ADALIMUMAB 40 MG EVERY THREE WEEKS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT ANALYSIS

Sophie Van Steenbergen  1     Sumin Bian  2     Vera Ballet  1     Severine Vermeire  3     Gert Van Assche     Ann Gils     Marc Ferrante    
1 University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium
2 KU Leuven, Laboratory for Therapeutic and Diagnostic Antibodies, Leuven, Belgium
3 University Hospitals Leuven, Department of Gastroenterology and Hepato

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing